Englisch

The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.

19 Formulare  
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000001.v2.p1
Beschreibung

pht000001.v2.p1

DUMMY ID NUMBER (EYE DISEASE RESEARCH ONLY PARTICIPANTS HAVE A DIFFERENT DUMMY ID NUMBER)
Beschreibung

ID2

Datentyp

string

NUMBER OF MATCHED GENETIC SPECIMENS FOR THE PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

MATCHSPEC

Datentyp

text

NUMBER OF UNTESTED GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

UNTESTSPEC

Datentyp

text

TOTAL NUMBER OF GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

TOTSPEC

Datentyp

text

AGE DOCTOR FIRST SAID HAD DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABAGE

Datentyp

text

YEARS TAKING INSULIN FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABINS

Datentyp

text

YEARS TAKING PILLS FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABPILL

Datentyp

text

YEARS CONTROLLING DIET FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABDIET

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT01

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT02

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT03

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT04

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT05

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT06

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT07

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT08

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT09

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT10

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT11

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT12

Datentyp

text

CURRENT DIABETES TREATMENT AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIABTRT13

Datentyp

text

AGE AT END OF CLINICAL TRIAL (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

AGECT

Datentyp

float

BASELINE NUCLEAR OPACITY SCORE: RIGHT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RNUCBASE

Datentyp

float

BASELINE NUCLEAR OPACITY SCORE: LEFT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LNUCBASE

Datentyp

float

FINAL PREDICTED NUCLEAR OPACITY SCORE: RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RNUCSCORE

Datentyp

float

FINAL PREDICTED NUCLEAR OPACITY SCORE: LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LNUCSCORE

Datentyp

float

BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RCORBASE

Datentyp

float

BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LCORBASE

Datentyp

float

FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RCORSCORE

Datentyp

float

FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LCORSCORE

Datentyp

float

BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RPSCBASE

Datentyp

float

BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LPSCBASE

Datentyp

float

FINAL PREDICTED PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RPSCSCORE

Datentyp

float

FINAL PREDICTED PSC OPACITY: PERCENTAGE CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
Beschreibung

LPSCSCORE

Datentyp

float

FINAL CATARACT PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CATARACT

Datentyp

text

FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RNUC

Datentyp

text

FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LNUC

Datentyp

text

FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

NUC

Datentyp

text

FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RCOR

Datentyp

text

FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LCOR

Datentyp

text

FINAL CORTICAL OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

COR

Datentyp

text

FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RPSC

Datentyp

text

FINAL PSC OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

LPSC

Datentyp

text

FINAL PSC OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

PSC

Datentyp

text

AGE AT RANDOMIZATION (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ENROLLAGE

Datentyp

float

AGE AT LAST FUNDUS PHOTO (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

AGEPHOT

Datentyp

float

BASELINE PARTICIPANT AMD CATEGORY (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

AMDCAT

Datentyp

text

AREDS TREATMENT ASSIGNMENT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

TRTCAT

Datentyp

text

MARITAL STATUS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

MARITAL

Datentyp

text

RACE OR ETHNIC BACKGROUND (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

RACE

Datentyp

text

SEX (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SEX

Datentyp

text

HIGHEST LEVEL OF SCHOOL ATTENDED (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SCHOOL

Datentyp

text

BODY-MASS INDEX AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI00

Datentyp

float

BODY-MASS INDEX AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI03

Datentyp

float

BODY-MASS INDEX AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI04

Datentyp

float

BODY-MASS INDEX AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI05

Datentyp

float

BODY-MASS INDEX AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI06

Datentyp

float

BODY-MASS INDEX AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI07

Datentyp

float

BODY-MASS INDEX AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI08

Datentyp

float

BODY-MASS INDEX AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI09

Datentyp

float

BODY-MASS INDEX AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI10

Datentyp

float

BODY-MASS INDEX AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI11

Datentyp

float

BODY-MASS INDEX AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI12

Datentyp

float

BODY-MASS INDEX AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

BMI13

Datentyp

float

SMOKING STATUS AT BASELINE - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK00

Datentyp

text

SMOKING STATUS AT YEAR 3 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK03

Datentyp

text

SMOKING STATUS AT YEAR 4 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK04

Datentyp

text

SMOKING STATUS AT YEAR 5 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK05

Datentyp

text

SMOKING STATUS AT YEAR 6 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK06

Datentyp

text

SMOKING STATUS AT YEAR 7 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK07

Datentyp

text

SMOKING STATUS AT YEAR 8 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK08

Datentyp

text

SMOKING STATUS AT YEAR 9 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK09

Datentyp

text

SMOKING STATUS AT YEAR 10 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK10

Datentyp

text

SMOKING STATUS AT YEAR 11 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK11

Datentyp

text

SMOKING STATUS AT YEAR 12 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK12

Datentyp

text

SMOKING STATUS AT YEAR 13 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SMK13

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST00

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST03

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST04

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST05

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST06

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST07

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST08

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST09

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST10

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST11

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST12

Datentyp

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

SYST13

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS00

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS03

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS04

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS05

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS06

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS07

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS08

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS09

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS10

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS11

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS12

Datentyp

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAS13

Datentyp

text

HISTORY OF DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB00

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB01

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB02

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB03

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB04

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB05

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB06

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB07

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB08

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB09

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB10

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB11

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB12

Datentyp

text

CURRENTLY HAVE DIABETES AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

DIAB13

Datentyp

text

HISTORY OF CANCER AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER00

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER01

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER02

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER03

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER04

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER05

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER06

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER07

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER08

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER09

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER10

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER11

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER12

Datentyp

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CANCER13

Datentyp

text

HISTORY OF ANGINA AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA00

Datentyp

text

HISTORY OF ANGINA AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA03

Datentyp

text

HISTORY OF ANGINA AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA04

Datentyp

text

HISTORY OF ANGINA AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA05

Datentyp

text

HISTORY OF ANGINA AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA06

Datentyp

text

HISTORY OF ANGINA AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA07

Datentyp

text

HISTORY OF ANGINA AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA08

Datentyp

text

HISTORY OF ANGINA AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA09

Datentyp

text

HISTORY OF ANGINA AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA10

Datentyp

text

HISTORY OF ANGINA AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA11

Datentyp

text

HISTORY OF ANGINA AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA12

Datentyp

text

HISTORY OF ANGINA AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

ANGINA13

Datentyp

text

TAKING CENTRUM DURING STUDY (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

CNTRMTAK

Datentyp

text

FINAL AMD PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Beschreibung

AMDSTAT

Datentyp

text

Zum Seitenanfang zurückkehren

Ähnliche Modelle

The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.

19 Formulare
  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
pht000001.v2.p1
ID2
Item
DUMMY ID NUMBER (EYE DISEASE RESEARCH ONLY PARTICIPANTS HAVE A DIFFERENT DUMMY ID NUMBER)
string
MATCHSPEC
Item
NUMBER OF MATCHED GENETIC SPECIMENS FOR THE PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
UNTESTSPEC
Item
NUMBER OF UNTESTED GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
TOTSPEC
Item
TOTAL NUMBER OF GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABAGE
Item
AGE DOCTOR FIRST SAID HAD DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Item
YEARS TAKING INSULIN FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABINS
Code List
YEARS TAKING INSULIN FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less then 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING PILLS FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABPILL
Code List
YEARS TAKING PILLS FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less then 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS CONTROLLING DIET FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABDIET
Code List
YEARS CONTROLLING DIET FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less then 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENT DIABETES TREATMENT AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT01
Code List
CURRENT DIABETES TREATMENT AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT02
Code List
CURRENT DIABETES TREATMENT AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT03
Code List
CURRENT DIABETES TREATMENT AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT04
Code List
CURRENT DIABETES TREATMENT AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT05
Code List
CURRENT DIABETES TREATMENT AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT06
Code List
CURRENT DIABETES TREATMENT AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT07
Code List
CURRENT DIABETES TREATMENT AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT08
Code List
CURRENT DIABETES TREATMENT AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT09
Code List
CURRENT DIABETES TREATMENT AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT10
Code List
CURRENT DIABETES TREATMENT AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT11
Code List
CURRENT DIABETES TREATMENT AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT12
Code List
CURRENT DIABETES TREATMENT AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABTRT13
Code List
CURRENT DIABETES TREATMENT AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
AGECT
Item
AGE AT END OF CLINICAL TRIAL (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RNUCBASE
Item
BASELINE NUCLEAR OPACITY SCORE: RIGHT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LNUCBASE
Item
BASELINE NUCLEAR OPACITY SCORE: LEFT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RNUCSCORE
Item
FINAL PREDICTED NUCLEAR OPACITY SCORE: RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LNUCSCORE
Item
FINAL PREDICTED NUCLEAR OPACITY SCORE: LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RCORBASE
Item
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LCORBASE
Item
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RCORSCORE
Item
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LCORSCORE
Item
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RPSCBASE
Item
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LPSCBASE
Item
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RPSCSCORE
Item
FINAL PREDICTED PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LPSCSCORE
Item
FINAL PREDICTED PSC OPACITY: PERCENTAGE CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
float
Item
FINAL CATARACT PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CATARACT
Code List
FINAL CATARACT PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (1)
CL Item
Nuclear alone (2)
CL Item
Cortical alone (3)
CL Item
PSC alone (4)
CL Item
Nuclear/Cortical (5)
CL Item
Nuclear/PSC (6)
CL Item
Cortical/PSC (7)
CL Item
Nuclear/Cortical/PSC (8)
CL Item
Cataract Surgery/No specific type (9)
CL Item
Questionable (10)
Item
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
RNUC
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (NUC-A)
CL Item
Present (NUC-B)
CL Item
Cataract Surgery (NUC-C)
CL Item
Questionable (NUC-D)
Item
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
LNUC
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (NUC-A)
CL Item
Present (NUC-B)
CL Item
Cataract Surgery (NUC-C)
CL Item
Questionable (NUC-D)
Item
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
NUC
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (0)
CL Item
Present (1)
CL Item
Cataract Surgery (2)
CL Item
Questionable (3)
Item
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
RCOR
Code List
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (COR-A)
CL Item
Present (COR-B)
CL Item
Cataract Surgery (COR-C)
CL Item
Questionable (COR-D)
Item
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
LCOR
Code List
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (COR-A)
CL Item
Present (COR-B)
CL Item
Cataract Surgery (COR-C)
CL Item
Questionable (COR-D)
Item
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
COR
Code List
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (0)
CL Item
Present (1)
CL Item
Cataract Surgery (2)
CL Item
Questionable (3)
Item
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
RPSC
Code List
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (PSC-A)
CL Item
Present (PSC-B)
CL Item
Cataract Surgery (PSC-C)
CL Item
Questionable (PSC-D)
Item
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
LPSC
Code List
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (PSC-A)
CL Item
Present (PSC-B)
CL Item
Cataract Surgery (PSC-C)
CL Item
Questionable (PSC-D)
Item
FINAL PSC OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
PSC
Code List
FINAL PSC OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (0)
CL Item
Present (1)
CL Item
Cataract Surgery (2)
CL Item
Questionable (3)
ENROLLAGE
Item
AGE AT RANDOMIZATION (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
AGEPHOT
Item
AGE AT LAST FUNDUS PHOTO (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
Item
BASELINE PARTICIPANT AMD CATEGORY (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
AMDCAT
Code List
BASELINE PARTICIPANT AMD CATEGORY (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
AMD Category 1 (1)
CL Item
AMD Category 2 (2)
CL Item
AMD Category 3a (3a)
CL Item
AMD Category 3b (3b)
CL Item
AMD Category 4a (4a)
CL Item
AMD Category 4b (4b)
Item
AREDS TREATMENT ASSIGNMENT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
TRTCAT
Code List
AREDS TREATMENT ASSIGNMENT (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Placebo (1)
CL Item
Antioxidants (2)
CL Item
Zinc (3)
CL Item
Antioxidants+Zinc (4)
Item
MARITAL STATUS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
MARITAL
Code List
MARITAL STATUS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Married (1)
CL Item
Divorced/separated (2)
CL Item
Widowed (3)
CL Item
Never married (4)
Item
RACE OR ETHNIC BACKGROUND (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
RACE
Code List
RACE OR ETHNIC BACKGROUND (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
White - not of Hispanic origin (1)
CL Item
Black - not of Hispanic origin (2)
CL Item
Hispanic (3)
CL Item
Asian or Pacific Islander (4)
CL Item
Other (5)
Item
SEX (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SEX
Code List
SEX (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Female (F)
CL Item
Male (M)
Item
HIGHEST LEVEL OF SCHOOL ATTENDED (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SCHOOL
Code List
HIGHEST LEVEL OF SCHOOL ATTENDED (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Grade 11 or less (1)
CL Item
High school graduate (2)
CL Item
Some college or associate degree (3)
CL Item
Bachelor's degree (4)
CL Item
Postgraduate work (5)
CL Item
Refused to answer (6)
BMI00
Item
BODY-MASS INDEX AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI03
Item
BODY-MASS INDEX AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI04
Item
BODY-MASS INDEX AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI05
Item
BODY-MASS INDEX AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI06
Item
BODY-MASS INDEX AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI07
Item
BODY-MASS INDEX AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI08
Item
BODY-MASS INDEX AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI09
Item
BODY-MASS INDEX AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI10
Item
BODY-MASS INDEX AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI11
Item
BODY-MASS INDEX AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI12
Item
BODY-MASS INDEX AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI13
Item
BODY-MASS INDEX AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
Item
SMOKING STATUS AT BASELINE - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK00
Code List
SMOKING STATUS AT BASELINE - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 3 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK03
Code List
SMOKING STATUS AT YEAR 3 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 4 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK04
Code List
SMOKING STATUS AT YEAR 4 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 5 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK05
Code List
SMOKING STATUS AT YEAR 5 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 6 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK06
Code List
SMOKING STATUS AT YEAR 6 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 7 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK07
Code List
SMOKING STATUS AT YEAR 7 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 8 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK08
Code List
SMOKING STATUS AT YEAR 8 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 9 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK09
Code List
SMOKING STATUS AT YEAR 9 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 10 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK10
Code List
SMOKING STATUS AT YEAR 10 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 11 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK11
Code List
SMOKING STATUS AT YEAR 11 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 12 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK12
Code List
SMOKING STATUS AT YEAR 12 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 13 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SMK13
Code List
SMOKING STATUS AT YEAR 13 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
SYST00
Item
SITTING SYSTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST03
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST04
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST05
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST06
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST07
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST08
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST09
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST10
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST11
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST12
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST13
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS00
Item
SITTING DIASTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS03
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS04
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS05
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS06
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS07
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS08
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS09
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS10
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS11
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS12
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS13
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Item
HISTORY OF DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB00
Code List
HISTORY OF DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB01
Code List
CURRENTLY HAVE DIABETES AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB02
Code List
CURRENTLY HAVE DIABETES AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB03
Code List
CURRENTLY HAVE DIABETES AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB04
Code List
CURRENTLY HAVE DIABETES AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB05
Code List
CURRENTLY HAVE DIABETES AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB06
Code List
CURRENTLY HAVE DIABETES AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB07
Code List
CURRENTLY HAVE DIABETES AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB08
Code List
CURRENTLY HAVE DIABETES AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB09
Code List
CURRENTLY HAVE DIABETES AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB10
Code List
CURRENTLY HAVE DIABETES AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB11
Code List
CURRENTLY HAVE DIABETES AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB12
Code List
CURRENTLY HAVE DIABETES AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAB13
Code List
CURRENTLY HAVE DIABETES AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF CANCER AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER00
Code List
HISTORY OF CANCER AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER01
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER02
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER03
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER04
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER05
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER06
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER07
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER08
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER09
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER10
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER11
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER12
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CANCER13
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA00
Code List
HISTORY OF ANGINA AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA03
Code List
HISTORY OF ANGINA AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA04
Code List
HISTORY OF ANGINA AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA05
Code List
HISTORY OF ANGINA AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA06
Code List
HISTORY OF ANGINA AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA07
Code List
HISTORY OF ANGINA AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA08
Code List
HISTORY OF ANGINA AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA09
Code List
HISTORY OF ANGINA AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA10
Code List
HISTORY OF ANGINA AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA11
Code List
HISTORY OF ANGINA AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA12
Code List
HISTORY OF ANGINA AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
ANGINA13
Code List
HISTORY OF ANGINA AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
TAKING CENTRUM DURING STUDY (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
CNTRMTAK
Code List
TAKING CENTRUM DURING STUDY (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
FINAL AMD PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
AMDSTAT
Code List
FINAL AMD PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Control (1)
CL Item
Control Questionable 1 (2)
CL Item
Control Questionable 2 (3)
CL Item
Control Questionable 3 (4)
CL Item
Control Questionable 4 (5)
CL Item
Large Drusen (6)
CL Item
Large Drusen Questionable 1 (7)
CL Item
Large Drusen Questionable 2 (8)
CL Item
Large Drusen Questionable 3 (9)
CL Item
Questionable AMD (10)
CL Item
NV AMD (11)
CL Item
GA (12)
CL Item
Both NV AMD and GA (13)
CL Item
Other non-control (14)
Zum Seitenanfang zurückkehren